Predicted protein targets (top 1)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | LMNA | P02545 | 1/20 | 0.32 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL13488459 | 0.69 | LMNA (0.35) | LMNA | |
| SCHEMBL10717017 | 0.69 | LMNA (0.35) | LMNA | |
| SCHEMBL13409413 | 0.67 | — | — | |
| SCHEMBL22697523 | 0.66 | TSHR (0.33) | — | |
| SCHEMBL13103905 | 0.65 | — | — | |
| SCHEMBL12562396 | 0.61 | — | — | |
| SCHEMBL27460431 | 0.61 | — | — | |
| Isopropyl Alcohol SCHEMBL1408797 | 0.61 | LMNA (0.38) | LMNA | |
| SCHEMBL20212036 | 0.60 | ALDH1A1 (0.30) | — | |
| SCHEMBL9439652 | 0.59 | OPRM1 (0.32) | LMNA |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20200369703-A1 | Modified oligonucleotides and compound that can be used for synthesizing same | GUANGZHOU RIBOBIO CO LTD (CN) | 2020-11-26 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20200369703-A1 | Modified oligonucleotides and compound that can be used for synthesizing same | POLRMT, RNASE1, ADAR | LMNA 1108/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.